Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care
Active
21 and under
Other
RASALL
NCT00186940
2.
Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
Over 15
Other
GMALL08
NCT00199043
3.
Evaluation of Rasburicase for Hyperuricemia Associated With Tumor Lysis Syndrome
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
No age specified
Other
RASBUR
NCT00247767
Last Modified:
10/11/2008
 
First Published:
3/24/2003
4.
Phase II Pilot Study of Rituximab Added to the Induction and Consolidation Phases and Rasburicase Added to the Reduction Phase in Children With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma Treated With LMB/FAB Therapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
1 to 29
NCI
COG-ANHL01P1
NCT00057811, ANHL01P1
5.
Rasburicase in Patients at Risk for Tumor Lysis Syndrome
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
Not specified
Other
2006-0918
NCT00628628
Last Modified:
4/22/2008
 
First Published:
7/24/2007
6.
Pilot Study of Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Other Diseases Undergoing Allogeneic Peripheral Blood Hematopoietic Stem Cell Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Biomarker/Laboratory analysis, Supportive care, Treatment
Active
18 to 65
Other
MGH-07-071
07-071, DFCI-07-071, NCT00513474
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute